![Stephen Sofen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Stephen Sofen worked as Vice President-Technical Operations at CRISPR Therapeutics AG from 2016 to 2018.
He also worked as Senior Vice President-Technical Operations at Kaleido Biosciences, Inc. Dr. Sofen completed his undergraduate degree at The Reed Institute and earned a doctorate degree from the University of California, Berkeley.
Eerdere bekende functies van Stephen Sofen
| Bedrijven | Functie | Einde |
|---|---|---|
| CRISPR THERAPEUTICS AG | Corporate Officer/Principal | 01-03-2018 |
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Opleiding van Stephen Sofen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
